Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/2296
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Cefprozil (Powder, For Suspension)
|
| dailymed-instance:dosage |
Renal Impairment:<br/>Hepatic Impairment:
|
| dailymed-instance:clinicalP... |
Microbiology:<br/>Susceptibility Tests:
|
| dailymed-instance:activeIng... | |
| dailymed-instance:genericDr... | |
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... |
dailymed-ingredient:Aspartame,
dailymed-ingredient:Bubble_Gum_Flavor,
dailymed-ingredient:Carboxymethylcellulose_Sodium,
dailymed-ingredient:Citric_Acid_Monohydrate,
dailymed-ingredient:Colloidal_Silicon_Dioxide,
dailymed-ingredient:FD&C_Red_No.3,
dailymed-ingredient:Glycine,
dailymed-ingredient:Microcrystalline_Cellulose,
dailymed-ingredient:Polysorbate_80,
dailymed-ingredient:Simethicone_Emulsion,
dailymed-ingredient:Sodium_Benzoate,
dailymed-ingredient:Sodium_Chloride,
dailymed-ingredient:Sucrose
|
| dailymed-instance:precautio... |
General:<br/>Information for Patients: Diarrhea is a common problem caused by antibiotics which usually ends when the antibiotic is discontinued. Sometimes after starting treatment with antibiotics, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibiotic. If this occurs, patients should contact their physician as soon as possible.<br/>Drug Interactions:<br/>Drug/Laboratory Test Interactions:<br/>Carcinogenesis, Mutagenesis, Impairment of Fertility:<br/>Pregnancy:<br/>Teratogenic effects:<br/>Labor and Delivery:<br/>Nursing Mothers:<br/>Pediatric Use:<br/>Geriatric Use:
|
| dailymed-instance:genericMe... |
Cefprozil
|
| dailymed-instance:fullName |
Cefprozil (Powder, For Suspension)
|
| dailymed-instance:warning |
Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including cefprozil, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile. C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Cefprozil
|